A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis.
Daan CaudriLidija TurkovicNicholas H de KlerkTimothy RosenowConor P MurrayEwout W SteyerbergSarath C RanganathanPeter D SlyStephen M StickOded Breuernull nullPublished in: Pediatric pulmonology (2021)
Early assessment of bronchiectasis risk in children with CF is feasible with reasonable precision at a group level, which can assist in high-risk patient selection for interventional trials. The unexplained variability in disease progression at individual patient levels remains high, limiting the use of this model as a clinical prediction tool.
Keyphrases